Study finds targeted cancer drugs may work in range of tumor types

CHICAGO, June 4 (Reuters) - Early results from a clinical

trial of Roche Holding AG cancer drugs released on

Saturday suggest some promise in matching treatments based on

abnormalities found in a patient's tumor rather than the organ

in which the cancer was originally detected.

Read more